Lancashire and South Cumbria
Formulary
Formulary
5 Infections
For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
This chapter of the formulary is under development, please use local/national antimicrobial guidelines to support prescribing choices.
For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
The formulary development team can be contacted here: mlcsu.lscformulary@nhs.net
Prescribers must follow the relevant local and national guidance when treating an infection. Some anti-infectives require approval from the local Trust microbiology team for use, consult local guidance for further information.Not all anti-infectives listed in this chapter will be available in all localities; availability will be guided by local need and resistance patterns. |
05-01-09 Antituberculosis drugs
| Bedaquiline |
|
Formulary
|
Tablets 100mg On advice of Microbiology or a respiratory consultant only. |
 NHSE: Clinical commissioning policy for resistant TB |
|
| Delamanid |
|
Formulary
|
Tablets 50mg On advice of Microbiology or a respiratory consultant only. |
 NHSE: Clinical commissioning policy statement (2317): treatment for defined patients with rifampicin resistant (RR) tuberculosis (TB), multidrug-resistant (MDR) TB, pre-extensively drug-resistant (pre-XDR) TB and extensively drug-resistant (XDR-TB) includ |
|
|
| Ethambutol |
|
Formulary
|
Tablets 100mg, 400mg |
|
|
| Isoniazid |
|
Formulary
|
Tablets 100mg Use Rifater® where possible. On advice of Microbiology or a respiratory consultant only. |
|
|
| Pretomanid |
|
Formulary
|
On advice of Microbiology or a respiratory consultant only. |
|
NHSE: Clinical commissioning policy for resistant TB |
|
|
| Pyrazinamide |
|
Formulary
|
Tablets 500mg Use Rifater® where possible On advice of Microbiology or a respiratory consultant only. |
|
|
| Rifampicin |
|
Formulary
|
Capsules 150mg, 300mg On advice of Microbiology or a respiratory consultant only. May be prescribed by GP upon consultant microbiologist advice. |
|
| Rifampicin |
|
Formulary
|
Intravenous infusion 600mg On advice of Microbiology or a respiratory consultant only. |
|
|
| Rifampicin and Isoniazid and Pyrazinamide Rifater® |
|
Formulary
|
Tablets rifampicin 120mg, isoniazid 50mg, pyrazinamide 300mg On advice of Microbiology or a respiratory consultant only. |
|
|
Links
- Blackpool Teaching Hospitals: Antimicrobial Formulary
- British Association for Sexual Health and HIV
- Central Lancashire/LSCFT/Morecambe Bay Primary Care: NICE Summary of antimicrobial prescribing guidance - managing common infections
- East Lancashire Primary Care: Antimicrobial guide primary care
- East Lancashire Secondary Care: Antimicrobial guide secondary care
- Lancashire Teaching Hospitals Secondary Care: Tap on the bugs app (App store)
- Lancashire Teaching Hospitals Secondary Care: Tap on the bugs app (Google)
- NHSE: Clinical commissioning policy for resistant TB
- NHSE: Clinical commissioning policy for resistant TB
- NHSE: Clinical commissioning policy statement (2317): treatment for defined patients with rifampicin resistant (RR) tuberculosis (TB), multidrug-resistant (MDR) TB, pre-extensively drug-resistant (pre-XDR) TB and extensively drug-resistant (XDR-TB) includ
- NICE CG165: Hepatitis B (chronic): diagnosis and management
- NICE NG110: Prostatitis (acute): antimicrobial prescribing
- NICE NG111: Pyelonephritis (acute): antimicrobial prescribing
- NICE NG114: Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing
- NICE NG117: Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing
- NICE NG120: Cough (acute): antimicrobial prescribing
- NICE NG125: Surgical site infections: prevention and treatment
- NICE NG138: Pneumonia (community-acquired): antimicrobial prescribing
- NICE NG139: Pneumonia (hospital-acquired): antimicrobial prescribing
- NICE NG141: Cellulitis and erysipelas: antimicrobial prescribing
- NICE NG152: Leg ulcer infection: antimicrobial prescribing
- NICE NG153: Impetigo: antimicrobial prescribing
- NICE NG182: Insect bites and stings: antimicrobial prescribing
- NICE NG184: Human and animal bites: antimicrobial prescribing
- NICE NG19: Diabetic foot problems: prevention and management
- NICE NG190: Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing
- NICE NG191: COVID-19 rapid guideline: managing COVID-19
- NICE NG198: Acne vulgaris: management
- NICE NG199: Clostridioides difficile infection: antimicrobial prescribing
- NICE NG240: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management
- NICE NG33: Tuberculosis
- NICE NG50: Cirrhosis in over 16s: assessment and management
- NICE NG51: Sepsis: recognition, diagnosis and early management
- NICE NG78: Cystic fibrosis: diagnosis and management
- NICE NG79: Sinusitis (acute): antimicrobial prescribing
- NICE NG84: Sore throat (acute): antimicrobial prescribing
- NICE NG91: Otitis media (acute): antimicrobial prescribing
- NICE NG95: Lyme disease
- University Hospitals of Morecambe Bay: Antimicrobial guide secondary care
- West Lancashire Primary Care: Pan Mersey antimicrobial guide
- WHO: AWaRe classification of antibiotics for evaluation and monitoring of use, 2023